Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
PHASE3
This clinical study compares the efficacy, safety, and tolerability of ther...
Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD
PHASE2
Chronic graft versus host diseasre (GVHD) is a serious reaction that might ...
Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis
PHASE3
The study AC-058B301 (OPTIMUM; NCT02425644) has been designed to investigat...